Insider buy
$Verve Therapeutics(VERV.US$ • Krishna Yeshwant, managing partner at Google Ventures and a director at Verve Therapeutics (NASDAQ:VERV), has acquired $18M in Verve common stock.
• In a transaction dated Dec 01, 2023, Yeshwant bought 1.8M shares of Verve's common stock at a price of $10 each.![]()
• In a transaction dated Dec 01, 2023, Yeshwant bought 1.8M shares of Verve's common stock at a price of $10 each.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
